These courses were pre-recorded. Join LIVE Q&A immediately following each presentation.
Moderator – Michael Norton, BDS, FDS, RCS(Ed)
10:00 – 10:25 am
Is Peri-implant Mucositis and Peri-implantitis an Inevitable Outcome?
Mario Roccuzzo, DDS
As utilization of dental implants continues to rise, so does the incidence of complications. Regardless of common thinking, long-term maintenance of healthy peri-implant tissues constitutes a major challenge for every clinician. It should be clear by now, that patients should be informed about their risk profile before treatment is initiated. On the other hand, biological complications, detected at an early stage, can be successfully treated by means of decontamination and/or regenerative surgery in a high percentage of cases.
Upon completion of this presentation, participants should be able to: 1) establish effective measures to reduce the risk of complications; 2) recognize situations where peri-implant soft tissue augmentations is recommended; and 3) select the ideal peri-implant regenerative surgical treatment.
10:25 – 10:50 am
Factors Contributing to Surgical Complications and Failures
Bach Le, DDS, MD
The predictability and long-term success rate of dental implants is well documented in the literature. Nevertheless, complications and failures occur and can have a significant impact on overall treatment. Failing implants and the consequences of implant removal usually results in significant loss of hard and soft tissues and jeopardize efforts to achieve satisfactory function and esthetics. This lecture will discuss risk factors for treatment failures and treatment modalities to deal with dental implant failure. When an implant fails, a customized treatment plan should be provided for each patient depending on the relevant needs. Patients should be informed regarding all possible treatment options and that achieving an ideal result in the compromised site is sometimes elusive, and in some cases impossible.
Upon completion of this presentation, participants should be able to: 1) identify risk factors associated with surgical complications; 2) explain the difference between patient-related versus site-related etiology for surgical complications and failures; and 3) describe treatment options to mitigate risks of surgical complications and failures.
10:50 – 11:15 am
Autogenous Teeth for Alveolar Ridge Augmentation
Frank Schwarz, DMD
Preclinical and clinical data provide clear evidence that tooth roots reveal a structural and biological potential to serve as alternative autografts for localized ridge augmentation. In fact, dentin has a similar anorganic and organic composition as bone and features osteoconductive as well as osteoinductive properties, while getting involved in the bone remodeling process. This presentation will elucidate this new biological concept and focus on associated surgical procedures for current clinical applications.
Upon completion of this presentation, participants should be able to: 1) discuss the biological background for using tooth roots for alveolar ridge augmentation; 2) select appropriate clinical indications and surgical protocols; and 3) evaluate the overall efficacy and safety of the procedure.
11:15 – 11:30 am
Q&A with Drs. Roccuzzo, Le and Schwarz
11:30 am – noon
Noon – 12:30 pm
Cell Therapies Applied to Bone Regeneration
Mariano Sanz, MD, DDS, PhD
Bone regenerative interventions remain an important part of implant practice and the advent of bioengineering opportunities enhances the possibility to obtain more predictable outcomes. In this presentation, I shall present the background of using autologous mesenchymal cells for bone regeneration and I shall convey my experience on the clinical use and results of applying adjunctive cell therapy to GBR approaches using synthetic biomaterials.
Upon completion of this presentation, participants should be able to: 1) discuss the potential of cell therapies in bone regeneration interventions; 2) describe the process of harvesting and applying autologous mesenchymal cells: and 3) assess the results obtained after the application of a cell therapy as adjunctive to GBR in bone regeneration prior to implant placement.
12:30 – 12:55 pm
Predicting and Averting Hard and Soft Tissue Complications
Rodrigo Neiva, DDS
New treatment options for hard and soft tissue development have been introduced to implant dentistry in recent years. This presentation is to discuss possible advantages, disadvantages, and realistic short- and long-term expectations of these new treatment modalities.
Upon completion of this presentation, participants should be able to: 1) explain the rationale for new materials and techniques; 2) discuss the advantages and disadvantages of the new treatments; and 3) select materials based on material properties and features.
12:55 – 1:20 pm
New Biologic Challenges in Implant Dentistry
J.E. Davies, BDS, PhD, DSc
This presentation will focus on new emerging evidence of the important biologic processes that precede bone formation in the earliest phase of osseointegration. We are all familiar with the sinusoidal curve of secondary healing first conceptualized by Raghavendra et al in 2005, which includes an initial lag phase. We now know that two important events occur during this phase of healing: peri-implant angiogenesis and the ingress of the mesenchymal progenitors that will become, among other cells, osteoblasts. Both of these phenomena are profoundly influenced by implant surface design and provide the important foundation for the bone formation that follows. Understanding these biologic events can provide new targets to accelerate the early healing that is so important in clinical practice.
Upon completion of this presentation, participants should be able to: 1) explain the important biologic processes that precede peri-implant bone formation; 2) discuss how these biologic phenomena are influenced by implant surface design; and 3) describe how these early events can accelerate secondary implant stability
1:20 – 1:35 pm
Q&A with Drs. Sanz, Neiva and Davies